TELA News and Press, TELA Bio Inc. From 04/19/23

2023-04-19 05:00:09 ET Commercial-stage medical technology company, TELA ( NASDAQ: TELA ) announced underwritten public offering of 4.75M shares at a price to the public of $9.50 per share. Gross proceeds of $45.125M. Underwriters have a 30-day option to purchase up to...

2023-04-18 16:14:59 ET Medical technology company TELA Bio ( NASDAQ: TELA ) said on Tuesday that it has commenced an underwritten public offering of shares. The company is offering all the shares. TELA said that there can be no assurance on the actual size or terms of the ...

MALVERN, Pa., March 29, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patie...

2023-03-23 07:30:53 ET MedTech company TELA Bio ( NASDAQ: TELA ) announced Thursday that the FDA issued 510(k) clearance for its OviTex PRS Long-Term Resorbable product, a device used for soft tissue repair or reinforcement in plastic and reconstructive surgery. OviTex PRS...

MALVERN, Pa., March 23, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy,...

2023-03-21 20:05:01 ET TELA Bio, Inc. (TELA) Q4 2022 Results Conference Call March 21, 2023 04:30 PM ET Company Participants Louisa Smith - Gilmartin Group Tony Koblish - President and CEO Roberto Cuca - COO and CFO Conference Call Participants Frank ...

2023-03-21 16:07:40 ET TELA Bio press release ( NASDAQ: TELA ): Q4 GAAP EPS of -$0.52 beats by $0.03 . Revenue of $11.6M (+38.6% Y/Y) misses by $1.59M . Gross profit was $8.2 million in the fourth quarter of 2022, or 70% of revenue, compared to $5.7 million, or...

MALVERN, Pa., March 21, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own an...

MALVERN, Pa., March 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patie...

MALVERN, Pa., Feb. 28, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the pa...